Health Care Law
Overview
Health care aims to prevent and treat illness and disease in order to maintain the physical and mental well-being of individuals. Nearly all industrialized nations provide universal, publicly-funded health care through a national system. The exception is the United States, where health care is largely provided by the private sector, although some public services are available for certain individuals.
State statutes comprise a large portion of law applicable to health care. State health care law ranges from regulation of the health insurance industry to rules governing cases of medical malpractice. State agencies and departments are usually responsible for implementing state health laws and regulations, as well as administering certain federally-funded health care programs.
Featured Cases
GUNVALSON et al v. PTC THERAPEUTICS, INC.
Plaintiffs Cheri and John Gunvalson, parents of Jacob Gunvalson, sought an order requiring Defendant PTC Therapeutics, Inc. to permit Jacob to participate as a protocol exception in the Phase IIa study extension for PTC124 for Duchenne Muscular Dystrophy. Alternatively, Plaintiffs sought an order that Defendant make available PTC124 to Jacob's pediatrician.
New Jersey District Court
Plaintiff
Filed: July 16, 2008
Plaintiff: JACOB GUNVALSON, CHERI AND JOHN GUNVALSON; Defendant: PTC THERAPEUTICS, INC.
Last Docket Filed: April 7, 2009
Legislation
Bill Enacted: H.R.3288 Department of Transportation Appropriations Act, 2010
Making appropriations for the Departments of Transportation, and Housing and Urban Development, and related agencies for the fiscal year ending September 30, 2010, and for other purposes.
December 16, 2009: Became Public Law No: 111-117.Bill Introduced: S.2860 A bill to protect students from inappropriate seclusion and physical ...
A bill to protect students from inappropriate seclusion and physical restraint, and for other purposes.Bill Introduced: H.R.4247 Preventing Harmful Restraint and Seclusion in Schools Act
To prevent and reduce the use of physical restraint and seclusion in schools, and for other purposes.Bill Introduced: H.R.4222 Prevent Health Care Fraud Act of 2009
To provide for the establishment of the Office of Deputy Secretary for Health Care Fraud Prevention.Bill Introduced: H.R.4190 Endocrine Disruption Prevention Act of 2009
To amend the Public Health Service Act to authorize the National Institute of Environmental Health Sciences to conduct a research program on endocrine disruption, to prevent and reduce the production of, and exposure to, chemicals that can undermine the development of children before they are born and cause lifelong impairment to their health and function, and for other purposes.
Regulations
Rule - Listing of Color Additives Exempt From Certification: Astaxanthin Dimethyldisuccinate; ...
Food and Drug Administration
Rule
Listing of Color Additives Exempt From Certification:
Astaxanthin Dimethyldisuccinate; Confirmation of Effective Date
,
5887 [2010-2522]
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 73 [Docket No. FDA-2007-C-0044] (formerly Docket No. 2007C-0474) Listing of Color Additives Exempt From Certification; Astaxanthin Dimethyldisuccinate; Confirmation of Effective Date AGENCY: Food and Drug Administration, HHS. ACTION: Final rule; confirmation of effective date. SUMMARY: The Food and Drug Administration (FDA) is confirming the effective date of December 8, 2009, for the final rule that appeared in... [read document]
View Document | Download PDFRule - Listing of Color Additives Exempt From Certification: Paracoccus Pigment; Confirmation ...
Food and Drug Administration
Rule
Listing of Color Additives Exempt From Certification:
Paracoccus Pigment; Confirmation of Effective Date
,
5887 [2010-2521]
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 73 [Docket No. FDA-2007-C-0456] (formerly Docket No. 2007C-0245) Listing of Color Additives Exempt From Certification; Paracoccus Pigment; Confirmation of Effective Date AGENCY: Food and Drug Administration, HHS. ACTION: Final rule; confirmation of effective date. SUMMARY: The Food and Drug Administration (FDA) is confirming the effective date of December 17, 2009, for the final rule that appeared in the Federal... [read document]
View Document | Download PDFRule - Listing of Color Additives Exempt From Certification: Ractopamine; Monensin
Food and Drug Administration
Rule
Listing of Color Additives Exempt From Certification:
Ractopamine; Monensin
,
5887-5888 [2010-2427]
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 558 [Docket No. FDA-2010-N-0002] New Animal Drugs for Use in Animal Feeds; Ractopamine; Monensin AGENCY: Food and Drug Administration, HHS. ACTION: Final rule. SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an original new animal drug application (NADA) filed by Elanco Animal Health, A Division of Eli Lilly and Co. The NADA provides for use of... [read document]
View Document | Download PDFRule - Interim Final Rules under the Paul Wellstone and Pete Domenici Mental Health Parity and ...
Centers for Medicare and Medicaid Services
Rule
Interim Final Rules under the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act (of 2008)
,
5410-5451 [2010-2167]
Tuesday, February 2, 2010 Part IV Department of the Treasury Internal Revenue Service 26 CFR Part 54 Department of Labor Employee Benefits Security Administration 29 CFR Part 2590 Department of Health and Human Services Centers for Medicare and Medicaid Services 45 CFR Part 146 Interim Final Rules Under the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008; Final Rule DEPARTMENT OF THE TREASURY Internal Revenue Service 26 CFR Part 54 [TD 9479] RIN... [read document]
View Document | Download PDFRule - Implantation or Injectable Dosage Form New Animal Drugs: Miconazole, Polymixin B, and ...
Food and Drug Administration
Rule
Implantation or Injectable Dosage Form New Animal Drugs:
Miconazole, Polymixin B, and Prednisolone Suspension
,
4692-4693 [2010-1794]
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 524 [Docket No. FDA-2010-N-0002] Ophthalmic and Topical Dosage Form New Animal Drugs; Miconazole, Polymixin B, and Prednisolone Suspension AGENCY: Food and Drug Administration, HHS. ACTION: Final rule. SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Janssen Pharmaceutica NV. The NADA provides for use of... [read document]
View Document | Download PDF
Articles
An Inquiry into the Theory, Causes and Consequences of Monitoring Indicators of Health and ...
IZA Discussion Paper No. 4734 Kostas Pouliakas and Ioannis Theodossiou University of Aberdeen - Business School and University of Aberdeen - Business School Date Posted: February 8, 2010 Last Revised: February 8, 2010Reaching Out to Do Justice: The Rise and Fall of the Special Docket of the U.S. Supreme Court
Arizona Legal Studies Discussion Paper No 10-04 Gabriel J. Chin and Sara Lindenbaum University of Arizona James E. Rogers College of Law and University of Arizona - James E. Rogers College of Law Date Posted: February 8, 2010 Last Revised: February 8, 2010State Law Responses to Global Warming: Is It Constitutional to Think Globally and Act Locally?
Pace Environmental Law Review, Vol. 21, pp. 53-81, 2003 David Hodas Widener University - School of Law Date Posted: February 8, 2010 Last Revised: February 8, 2010Can You Hear Me Up There? Giving Voice to Local Communities Imperative for Achieving Sustainability
Environmental & Energy Law & Policy Journal, Vol. 4, p. 256, 2009 Patricia Salkin Albany Law School Date Posted: February 8, 2010 Last Revised: February 8, 2010Imagining the Unimaginable: Reducing U.S. Greenhouse Gas Emissions by Forty Percent
Virginia Environmental Law Journal, Vol. 26, pp. 271-290, 2008 David Hodas Widener University - School of Law Date Posted: February 8, 2010 Last Revised: February 8, 2010
